title: Outcome of mild cognitive impairment comparing early memory profiles.
abstract: BACKGROUND
  : Finding variables that predict decline or stability in persons with amnestic mild cognitive impairment (aMCI) is an important step in identifying subjects in prodromal stages of dementia. This study tests a clinical observation suggesting that aMCI cases with better-preserved recognition skills, despite similar delayed recall deficits, are more likely to remain functionally stable.
  
  
  METHODS
  : A cohort of 210 cases with aMCI, diagnosed with standardized criteria that had been followed up for 48 ± 12 months (range: 36-100), were divided into two groups according to their initial recognition memory discrimination index (DI) on the Hopkins Verbal Learning Test (DI ≥ or <8). We compared the two groups according to demographic and neuropsychological variables, cerebral small vessel disease, and outcome (progression to dementia versus stability as aMCI).
  
  
  RESULTS
  : Thirty-seven percent progressed to dementia. In the group with the higher DI scores (n = 107), only 21.5% of the cases converted, compared with 52.4% of lower scorers (n = 103; Fisher's test: p < 0.0001). Progression to dementia occurred significantly later in cases with higher DI (50 ± 17 versus 26 ± 11 months in cases with impaired DI, Mann-Whitney test, U statistic = 1092.5, p < 0.0001). The group with lower DI showed a threefold-increased rate of progression to dementia. A multivariate regression model revealed DI, delayed recall, age, and family history of dementia as the strongest predictors of dementia, in this order.
  
  
  CONCLUSIONS
  : The aMCI patients with better-preserved recognition at baseline have a more benign prognosis. Detection of these cases may aid in isolating other aMCI cases that are already in prodromal stages of AD and in selecting more homogeneous groups for clinical trials.
authors.affiliation: Department of Neurology, Instituto de Investigación Sanitaria, Fundación Jiménez Díaz, Neuroradiology Section, Fundación Jiménez Díaz, Madrid, Spain. egomezt@fjd.es
authors.forename: Estrella
authors.initials: E
authors.lastname: Gómez-Tortosa
authors.forename: Ignacio
authors.initials: I
authors.lastname: Mahillo-Fernández
authors.forename: Rosa
authors.initials: R
authors.lastname: Guerrero
authors.forename: Julia
authors.initials: J
authors.lastname: Montoya
authors.forename: Ana
authors.initials: A
authors.lastname: Alonso
authors.forename: M José
authors.initials: MJ
authors.lastname: Sainz
mesh_terms: D000367:Age Factors; D000368:Aged; D000647:Amnesia / Q000150:complications / Q000235:genetics / Q000523:psychology*; D001057:Apolipoproteins E / Q000235:genetics; D060825:Cognitive Dysfunction / Q000150:complications / Q000235:genetics / Q000523:psychology*; D018450:Disease Progression; D005192:Family Health; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011939:Mental Recall; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data; D021641:Recognition, Psychology
chemical_list: D001057:Apolipoproteins E